Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
The Lymphoma Academic Research Organisation
The Lymphoma Academic Research Organisation
Dana-Farber Cancer Institute
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Henan Cancer Hospital
Centre Antoine Lacassagne
Hospices Civils de Lyon
Incyte Corporation
Insel Gruppe AG, University Hospital Bern
BeiGene
International Extranodal Lymphoma Study Group (IELSG)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Juno Therapeutics, a Subsidiary of Celgene
Antengene Corporation
M.D. Anderson Cancer Center
Celgene
BeiGene
BeiGene
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Novartis
Debiopharm International SA
CTI BioPharma
Beijing InnoCare Pharma Tech Co., Ltd.
Novartis
IRCCS San Raffaele
University Hospital Muenster
University of Nebraska
University of Nebraska
Juno Therapeutics, a Subsidiary of Celgene
National Institutes of Health Clinical Center (CC)
Sunnybrook Health Sciences Centre
University of Nebraska
MorphoSys AG
Hoffmann-La Roche
University of Nebraska
Sun Yat-sen University
University of Nebraska
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
Sierra Oncology LLC - a GSK company
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Jewish General Hospital
M.D. Anderson Cancer Center
The Lymphoma Academic Research Organisation
Medical College of Wisconsin
Eisai Inc.
Medical College of Wisconsin